Stoke Therapeutics, Inc.
STOK
$26.10
-$3.94-13.12%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -23.48M | 112.88M | -10.48M | -26.43M | -25.70M |
| Total Depreciation and Amortization | 446.00K | 477.00K | 526.00K | 540.00K | 548.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.74M | 6.86M | 6.94M | 7.52M | 7.70M |
| Change in Net Operating Assets | -11.12M | 11.61M | -20.18M | -3.24M | -30.00K |
| Cash from Operations | -25.42M | 131.83M | -23.19M | -21.62M | -17.48M |
| Capital Expenditure | -154.00K | -152.00K | -42.00K | -103.00K | -46.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -148.32M | 13.78M | 861.00K | -29.90M | -88.23M |
| Cash from Investing | -148.48M | 13.63M | 819.00K | -30.00M | -88.28M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 554.00K | 1.37M | 568.00K | 8.16M | 120.65M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 554.00K | 1.37M | 568.00K | 8.16M | 120.65M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -173.35M | 146.83M | -21.81M | -43.46M | 14.90M |